id	sid	eid	entity	type
bptjm-29	1	1	berkeley pharma tech journal	ORG
bptjm-29	1	2	august 12	DATE
bptjm-29	1	3	2022	CARDINAL
bptjm-29	1	4	october 24	DATE
bptjm-29	1	5	2022	CARDINAL
bptjm-29	1	6	december 28	DATE
bptjm-29	1	7	2022	CARDINAL
bptjm-29	1	8	4.0	CARDINAL
bptjm-29	6	1	als	ORG
bptjm-29	7	1	tanvi yalamanchili	PERSON
bptjm-29	7	2	saahil mohta	PERSON
bptjm-29	7	3	donna tran 1	PERSON
bptjm-29	8	1	als	ORG
bptjm-29	9	1	paralysis1	PERSON
bptjm-29	11	1	two	CARDINAL
bptjm-29	11	2	muscles2	PERSON
bptjm-29	12	1	cord1	WORK_OF_ART
bptjm-29	13	1	greek	NORP
bptjm-29	14	1	als	ORG
bptjm-29	15	1	bloodstream7	ORG
bptjm-29	16	1	als	ORG
bptjm-29	16	2	1869	DATE
bptjm-29	16	3	french	NORP
bptjm-29	16	4	jean-martin charcot	PERSON
bptjm-29	16	5	lou gehrig	PERSON
bptjm-29	16	6	lou gehrig	PERSON
bptjm-29	16	7	als	ORG
bptjm-29	16	8	the age of 36	DATE
bptjm-29	17	1	yankee	NORP
bptjm-29	17	2	un	ORG
bptjm-29	18	1	als causes motor neuron	ORG
bptjm-29	18	2	away1	DATE
bptjm-29	24	1	berkeley pharma tech journal	ORG
bptjm-29	24	2	71	CARDINAL
bptjm-29	25	1	around 5000	CARDINAL
bptjm-29	25	2	every year	DATE
bptjm-29	25	3	every 90 minutes	TIME
bptjm-29	26	1	two	CARDINAL
bptjm-29	27	1	ages greater than 60 years	DATE
bptjm-29	27	2	well6	ORG
bptjm-29	28	1	two	CARDINAL
bptjm-29	28	2	als	ORG
bptjm-29	28	3	als	ORG
bptjm-29	28	4	sals)7	NORP
bptjm-29	29	1	als	ORG
bptjm-29	29	2	only 5-10%	CARDINAL
bptjm-29	29	3	als	ORG
bptjm-29	30	1	sals6,7	ORG
bptjm-29	32	1	over 20	CARDINAL
bptjm-29	33	1	1	CARDINAL
bptjm-29	33	2	als	ORG
bptjm-29	34	1	als	ORG
bptjm-29	35	1	als	ORG
bptjm-29	35	2	90-95%	PERCENT
bptjm-29	35	3	cases6,7	ORG
bptjm-29	36	1	als	ORG
bptjm-29	37	1	disease6	ORG
bptjm-29	39	1	als	ORG
bptjm-29	40	1	als	ORG
bptjm-29	41	1	four	CARDINAL
bptjm-29	42	1	fda	ORG
bptjm-29	42	2	edaravone9	PERSON
bptjm-29	43	1	transplantation9	PERSON
bptjm-29	44	1	berkeley pharma tech journal	ORG
bptjm-29	44	2	72	DATE
bptjm-29	44	3	https://www.zotero.org/google-docs/?broken=48p26	GPE
bptjm-29	45	1	als	ORG
bptjm-29	46	1	mscs	ORG
bptjm-29	50	1	connectivity10	ORG
bptjm-29	52	1	2	CARDINAL
bptjm-29	52	2	2.1	CARDINAL
bptjm-29	60	1	neurons12	PERSON
bptjm-29	61	1	berkeley pharma tech journal	ORG
bptjm-29	61	2	73	CARDINAL
bptjm-29	61	3	organelle9	GPE
bptjm-29	66	1	als models	ORG
bptjm-29	68	1	neurodegeneration13	GPE
bptjm-29	70	1	2.2	CARDINAL
bptjm-29	75	1	one	CARDINAL
bptjm-29	76	1	berkeley pharma tech journal	ORG
bptjm-29	76	2	74	CARDINAL
bptjm-29	77	1	it16	PRODUCT
bptjm-29	78	1	terminal9	GPE
bptjm-29	80	1	neurons7	ORG
bptjm-29	84	1	degeneration13	PERSON
bptjm-29	85	1	cells13	GPE
bptjm-29	87	1	degeneration13	PERSON
bptjm-29	88	1	2.3	CARDINAL
bptjm-29	88	2	als	ORG
bptjm-29	89	1	disease20	GPE
bptjm-29	90	1	injury9	LOC
bptjm-29	91	1	berkeley pharma tech journal	ORG
bptjm-29	91	2	75	CARDINAL
bptjm-29	93	1	https://www.zotero.org/google-docs/?i63i3p	PERSON
bptjm-29	93	2	https://www.zotero.org/google-docs/?i63i3p https://www.zotero.org/google-docs/?knvyc7 https://www.zotero.org/google-docs/?p46f10	PERSON
bptjm-29	93	3	neurons21	GPE
bptjm-29	94	1	neurons22	GPE
bptjm-29	97	1	two	CARDINAL
bptjm-29	98	1	death9	PERSON
bptjm-29	99	1	neurons23	PERSON
bptjm-29	104	1	cleft9	PERSON
bptjm-29	106	1	degeneration20	GPE
bptjm-29	109	1	als pathogenesis	ORG
bptjm-29	110	1	berkeley pharma tech journal	ORG
bptjm-29	110	2	76	CARDINAL
bptjm-29	115	1	damage28	GPE
bptjm-29	117	1	als	ORG
bptjm-29	121	1	als	ORG
bptjm-29	123	1	enzyme9	PERSON
bptjm-29	124	1	als	ORG
bptjm-29	125	1	ros	CARDINAL
bptjm-29	127	1	berkeley pharma tech journal	ORG
bptjm-29	127	2	77	CARDINAL
bptjm-29	127	3	https://www.zotero.org/google-docs/?oiih9	PERSON
bptjm-29	127	4	1	CARDINAL
bptjm-29	128	1	four	CARDINAL
bptjm-29	129	1	3	CARDINAL
bptjm-29	129	2	3.1	CARDINAL
bptjm-29	131	1	1990s28	CARDINAL
bptjm-29	138	1	the late 20th century	DATE
bptjm-29	139	1	1994	DATE
bptjm-29	139	2	fda	ORG
bptjm-29	139	3	1995	DATE
bptjm-29	139	4	berkeley pharma tech journal	ORG
bptjm-29	139	5	cns30	GPE
bptjm-29	140	1	a one year	DATE
bptjm-29	141	1	1996	DATE
bptjm-29	141	2	100 mg	QUANTITY
bptjm-29	143	1	conformation32	NORP
bptjm-29	146	1	1995	DATE
bptjm-29	146	2	fda	ORG
bptjm-29	146	3	trials33	LOC
bptjm-29	147	1	two to three months	DATE
bptjm-29	148	1	als	ORG
bptjm-29	148	2	six to 19 months	DATE
bptjm-29	150	1	2017	DATE
bptjm-29	150	2	fda	ORG
bptjm-29	150	3	second	ORDINAL
bptjm-29	152	1	damage36	ORG
bptjm-29	153	1	berkeley pharma tech journal	ORG
bptjm-29	154	1	79	CARDINAL
bptjm-29	156	1	3	CARDINAL
bptjm-29	156	2	mobility37	ORG
bptjm-29	157	1	fda	ORG
bptjm-29	157	2	may 5, 2017	DATE
bptjm-29	159	1	up to an hour	TIME
bptjm-29	160	1	may 12	DATE
bptjm-29	160	2	2022	DATE
bptjm-29	160	3	fda	ORG
bptjm-29	161	1	radicava	PERSON
bptjm-29	161	2	two	CARDINAL
bptjm-29	162	1	bbb	ORG
bptjm-29	165	1	spb	ORG
bptjm-29	166	1	september 29	DATE
bptjm-29	166	2	2022	DATE
bptjm-29	166	3	fda	ORG
bptjm-29	167	1	u.s.	GPE
bptjm-29	167	2	als	ORG
bptjm-29	168	1	fda	ORG
bptjm-29	169	1	berkeley pharma tech journal	ORG
bptjm-29	170	1	80	CARDINAL
bptjm-29	170	2	https://www.zotero.org/google-docs/?imtdv2	GPE
bptjm-29	170	3	https://www.zotero.org/google-docs/?07j7p8	GPE
bptjm-29	170	4	three and six months	DATE
bptjm-29	171	1	nearly a decade	DATE
bptjm-29	171	2	justin klee	PERSON
bptjm-29	171	3	josh cohen	PERSON
bptjm-29	172	1	two	CARDINAL
bptjm-29	173	1	spb	ORG
bptjm-29	175	1	2:1	CARDINAL
bptjm-29	175	2	spb	ORG
bptjm-29	176	1	the six month period of daily	DATE
bptjm-29	176	2	the alsfrs-r. als	ORG
bptjm-29	177	1	als	ORG
bptjm-29	177	2	fda	ORG
bptjm-29	178	1	als	ORG
bptjm-29	179	1	als	ORG
bptjm-29	182	1	als	ORG
bptjm-29	183	1	berkeley pharma tech journal	ORG
bptjm-29	183	2	81	CARDINAL
bptjm-29	183	3	1	CARDINAL
bptjm-29	184	1	als 4	ORG
bptjm-29	185	1	two	CARDINAL
bptjm-29	185	2	1	CARDINAL
bptjm-29	185	3	2	CARDINAL
bptjm-29	187	1	1	CARDINAL
bptjm-29	187	2	30	CARDINAL
bptjm-29	188	1	ros	CARDINAL
bptjm-29	190	1	15–20%	PERCENT
bptjm-29	194	1	berkeley pharma tech journal	ORG
bptjm-29	195	1	82	CARDINAL
bptjm-29	195	2	ros	CARDINAL
bptjm-29	195	3	axons9	DATE
bptjm-29	197	1	rnase h	ORG
bptjm-29	198	1	1/2	CARDINAL
bptjm-29	198	2	36%	PERCENT
bptjm-29	202	1	als	ORG
bptjm-29	205	1	aso	ORG
bptjm-29	206	1	als	ORG
bptjm-29	208	1	berkeley pharma tech journal	ORG
bptjm-29	208	2	83	CARDINAL
bptjm-29	208	3	2	CARDINAL
bptjm-29	209	1	5	CARDINAL
bptjm-29	209	2	astrocyte	PERSON
bptjm-29	213	1	als	ORG
bptjm-29	214	1	astrocyte	PERSON
bptjm-29	217	1	berkeley pharma tech journal	ORG
bptjm-29	217	2	84	CARDINAL
bptjm-29	218	1	1/2a	DATE
bptjm-29	218	2	als	ORG
bptjm-29	218	3	survival44	ORG
bptjm-29	220	1	gdnf	PERSON
bptjm-29	221	1	two	CARDINAL
bptjm-29	222	1	two	CARDINAL
bptjm-29	223	1	msod1	ORG
bptjm-29	223	2	msod1	ORG
bptjm-29	229	1	6	CARDINAL
bptjm-29	229	2	msc	PERSON
bptjm-29	229	3	als	ORG
bptjm-29	229	4	berkeley pharma tech journal	ORG
bptjm-29	229	5	85	CARDINAL
bptjm-29	229	6	therapeutics46	DATE
bptjm-29	232	1	cells47	GPE
bptjm-29	233	1	four	CARDINAL
bptjm-29	233	2	mesenchymal48	ORG
bptjm-29	234	1	6.1	CARDINAL
bptjm-29	237	1	50	CARDINAL
bptjm-29	237	2	6.2	CARDINAL
bptjm-29	238	1	three	CARDINAL
bptjm-29	240	1	berkeley pharma tech journal	ORG
bptjm-29	240	2	86	CARDINAL
bptjm-29	243	1	6.3	CARDINAL
bptjm-29	245	1	lines54	NORP
bptjm-29	247	1	2	CARDINAL
bptjm-29	250	1	berkeley pharma tech journal	ORG
bptjm-29	250	2	87	CARDINAL
bptjm-29	250	3	toward56	GPE
bptjm-29	253	1	als	ORG
bptjm-29	259	1	vivo57	GPE
bptjm-29	259	2	55	DATE
bptjm-29	260	1	6.4	CARDINAL
bptjm-29	261	1	cord7	ORG
bptjm-29	262	1	berkeley pharma tech journal	ORG
bptjm-29	262	2	https://www.zotero.org/google-docs/?m9egga https://www.zotero.org/google-docs/?bopw39 https://www.zotero.org/google-docs/?evkrhb	PERSON
bptjm-29	272	1	system8	ORG
bptjm-29	273	1	berkeley pharma tech journal	ORG
bptjm-29	273	2	89	CARDINAL
bptjm-29	278	1	mscs	ORG
bptjm-29	280	1	one	CARDINAL
bptjm-29	281	1	rodent purkinje	ORG
bptjm-29	281	2	cerebellum56	NORP
bptjm-29	283	1	mscs	ORG
bptjm-29	284	1	msc exosomes	PERSON
bptjm-29	286	1	healing61	LANGUAGE
bptjm-29	286	2	msc	PERSON
bptjm-29	287	1	berkeley pharma tech journal	ORG
bptjm-29	287	2	90	CARDINAL
bptjm-29	287	3	medicine56	PRODUCT
bptjm-29	288	1	mscs	ORG
bptjm-29	290	1	1	CARDINAL
bptjm-29	290	2	2	CARDINAL
bptjm-29	291	1	approximately 90-95%	CARDINAL
bptjm-29	293	1	3	CARDINAL
bptjm-29	299	1	als	ORG
bptjm-29	300	1	berkeley pharma tech journal	ORG
bptjm-29	300	2	91	CARDINAL
bptjm-29	302	1	one	CARDINAL
bptjm-29	308	1	one	CARDINAL
bptjm-29	308	2	msc	ORG
bptjm-29	308	3	cells64	ORG
bptjm-29	309	1	two days	DATE
bptjm-29	309	2	12 days	DATE
bptjm-29	309	3	90%	PERCENT
bptjm-29	309	4	neurons65	PERSON
bptjm-29	311	1	als	ORG
bptjm-29	313	1	berkeley pharma tech journal	ORG
bptjm-29	313	2	92	CARDINAL
bptjm-29	315	1	3	CARDINAL
bptjm-29	318	1	one	CARDINAL
bptjm-29	324	1	berkeley pharma tech journal	ORG
bptjm-29	324	2	93	CARDINAL
bptjm-29	328	1	als	ORG
bptjm-29	331	1	angiogenesis8	GPE
bptjm-29	332	1	als	ORG
bptjm-29	332	2	plasticity7	LOC
bptjm-29	334	1	8	CARDINAL
bptjm-29	334	2	als	ORG
bptjm-29	335	1	msc	PERSON
bptjm-29	336	1	als	ORG
bptjm-29	336	2	berkeley pharma tech journal	ORG
bptjm-29	337	1	94	CARDINAL
bptjm-29	337	2	als	ORG
bptjm-29	338	1	als	ORG
bptjm-29	339	1	msc	NORP
bptjm-29	339	2	vegf	PERSON
bptjm-29	339	3	factors71	ORG
bptjm-29	340	1	monthly	DATE
bptjm-29	341	1	atp levels70	PERSON
bptjm-29	343	1	9	CARDINAL
bptjm-29	345	1	cell56	GPE
bptjm-29	346	1	berkeley pharma tech journal	ORG
bptjm-29	346	2	95	CARDINAL
bptjm-29	347	1	resolved59	ORG
bptjm-29	348	1	homeostasis8	PERSON
bptjm-29	350	1	msc quality8	PERSON
bptjm-29	351	1	repair74	ORG
bptjm-29	354	1	msc	PERSON
bptjm-29	355	1	msc exosomes	PERSON
bptjm-29	355	2	growth8	ORG
bptjm-29	357	1	berkeley pharma tech journal	ORG
bptjm-29	357	2	96	CARDINAL
bptjm-29	358	1	chemicals75	PERSON
bptjm-29	360	1	mscs	ORG
bptjm-29	361	1	10	CARDINAL
bptjm-29	363	1	als	ORG
bptjm-29	366	1	one	CARDINAL
bptjm-29	366	2	two	CARDINAL
bptjm-29	366	3	msc	PERSON
bptjm-29	366	4	als	ORG
bptjm-29	367	1	als	ORG
bptjm-29	368	1	msc	PERSON
bptjm-29	368	2	als	ORG
bptjm-29	369	1	berkeley pharma tech journal	ORG
bptjm-29	369	2	97	CARDINAL
bptjm-29	370	1	berkeley pharma tech journal	ORG
bptjm-29	370	2	98	CARDINAL
bptjm-29	370	3	1	CARDINAL
bptjm-29	371	1	als	ORG
bptjm-29	372	1	the als association	ORG
bptjm-29	373	1	july 23	DATE
bptjm-29	373	2	2022	CARDINAL
bptjm-29	374	1	2	CARDINAL
bptjm-29	375	1	columbia university motor neuron center	ORG
bptjm-29	376	1	july 23	DATE
bptjm-29	376	2	2022	CARDINAL
bptjm-29	377	1	3	CARDINAL
bptjm-29	377	2	lou gehrig	PERSON
bptjm-29	377	3	als	ORG
bptjm-29	378	1	the als association	ORG
bptjm-29	378	2	july 23	DATE
bptjm-29	378	3	2022	CARDINAL
bptjm-29	379	1	https://www.als.org/understanding-als/lou-gehrig 4	GPE
bptjm-29	380	1	als/mnd	ORG
bptjm-29	380	2	als	ORG
bptjm-29	381	1	july 23	DATE
bptjm-29	381	2	2022	CARDINAL
bptjm-29	382	1	5	CARDINAL
bptjm-29	383	1	july 23	DATE
bptjm-29	383	2	2022	CARDINAL
bptjm-29	384	1	6	CARDINAL
bptjm-29	384	2	als	ORG
bptjm-29	384	3	lou gehrig	PERSON
bptjm-29	385	1	july 23	DATE
bptjm-29	385	2	2022	CARDINAL
bptjm-29	386	1	7	CARDINAL
bptjm-29	386	2	bonafede	PERSON
bptjm-29	386	3	r. als	PERSON
bptjm-29	388	1	2017;11:80.	CARDINAL
bptjm-29	389	1	doi:10.3389	ORG
bptjm-29	389	2	fncel.2017.00080 8	DATE
bptjm-29	390	1	als sciencedirect	ORG
bptjm-29	391	1	july 23	DATE
bptjm-29	391	2	2022	CARDINAL
bptjm-29	392	1	1008211000918?via%3dihub 9	DATE
bptjm-29	392	2	czarzasta	PERSON
bptjm-29	392	3	siwek t	GPE
bptjm-29	392	4	maksymowicz w	GPE
bptjm-29	392	5	wojtkiewicz j. stem	PERSON
bptjm-29	393	1	j dev neurosci	PERSON
bptjm-29	394	1	2017;57:46-55	DATE
bptjm-29	395	1	zhang y,	PERSON
bptjm-29	395	2	li x	PERSON
bptjm-29	395	3	fu ql	PERSON
bptjm-29	399	1	nci dictionary	ORG
bptjm-29	399	2	nci	ORG
bptjm-29	400	1	february 2, 2011	DATE
bptjm-29	401	1	july 23	DATE
bptjm-29	401	2	2022	CARDINAL
bptjm-29	403	1	12	CARDINAL
bptjm-29	406	1	j neurol sci	PERSON
bptjm-29	406	2	2001;191(1-2):25-33	QUANTITY
bptjm-29	406	3	doi:10.1016	GPE
bptjm-29	406	4	13	CARDINAL
bptjm-29	407	1	verma m	PERSON
bptjm-29	407	2	chu ct	PERSON
bptjm-29	410	1	2022;11(1):3	PERSON
bptjm-29	411	1	2022	CARDINAL
bptjm-29	411	2	jan 25	DATE
bptjm-29	413	1	cleveland clinic	ORG
bptjm-29	414	1	july 23	DATE
bptjm-29	414	2	2022	CARDINAL
bptjm-29	415	1	https://my.clevelandclinic.org/health/articles/22839-glu	CARDINAL
bptjm-29	415	2	15	CARDINAL
bptjm-29	417	1	cleveland	GPE
bptjm-29	418	1	july 23	DATE
bptjm-29	418	2	2022	CARDINAL
bptjm-29	419	1	16	CARDINAL
bptjm-29	420	1	ruiz-soto	PERSON
bptjm-29	420	2	j.	PERSON
bptjm-29	422	1	berkeley pharma tech journal	ORG
bptjm-29	422	2	99	CARDINAL
bptjm-29	426	1	neurol engl ed	ORG
bptjm-29	427	1	2019;34(1):27-37	DATE
bptjm-29	428	1	doi:10.1016/j.nrleng.2015.12.019 17	ORG
bptjm-29	431	1	july 23	DATE
bptjm-29	431	2	2022	CARDINAL
bptjm-29	432	1	18	CARDINAL
bptjm-29	433	1	cappella m	ORG
bptjm-29	433	2	querin g	PERSON
bptjm-29	436	1	jnd-200531 19	DATE
bptjm-29	437	1	july 23	DATE
bptjm-29	437	2	2022	CARDINAL
bptjm-29	438	1	https://www.abcam.com/content/neuronal-calcium-sig	CARDINAL
bptjm-29	438	2	20	CARDINAL
bptjm-29	440	1	the als association	ORG
bptjm-29	440	2	july 23	DATE
bptjm-29	440	3	2022	CARDINAL
bptjm-29	442	1	liu j	PERSON
bptjm-29	442	2	wang f. role	PERSON
bptjm-29	444	1	2017;8:1005	CARDINAL
bptjm-29	445	1	22	CARDINAL
bptjm-29	447	1	oxford	NORP
bptjm-29	448	1	23	CARDINAL
bptjm-29	449	1	the als association	ORG
bptjm-29	449	2	july 23	DATE
bptjm-29	449	3	2022	DATE
bptjm-29	450	1	zhao w	PERSON
bptjm-29	450	2	appel	PERSON
bptjm-29	451	1	j neuroimmune pharmacol	PERSON
bptjm-29	451	2	j soc neuroimmune pharmacol	PERSON
bptjm-29	452	1	2013;8(4):888	CARDINAL
bptjm-29	452	2	25	CARDINAL
bptjm-29	453	1	betteridge	ORG
bptjm-29	456	1	2000;49(2	CARDINAL
bptjm-29	456	2	doi:10.1016	GPE
bptjm-29	457	1	li r	PERSON
bptjm-29	457	2	jia z	PERSON
bptjm-29	457	3	trush ma	PERSON
bptjm-29	458	1	nc	GPE
bptjm-29	458	2	2016;1(1):9-21	DATE
bptjm-29	459	1	27	CARDINAL
bptjm-29	461	1	july 23	DATE
bptjm-29	461	2	2022	CARDINAL
bptjm-29	462	1	https://medlineplus.gov/genetics/gene/sod1/ 28	DATE
bptjm-29	464	1	july 23	DATE
bptjm-29	464	2	2022	CARDINAL
bptjm-29	465	1	20-0033?url_ver	QUANTITY
bptjm-29	465	2	29	CARDINAL
bptjm-29	468	1	july 23	DATE
bptjm-29	468	2	2022	CARDINAL
bptjm-29	469	1	8294 30	DATE
bptjm-29	470	1	bensimon g	PERSON
bptjm-29	472	1	1994;330(9):585-591	CARDINAL
bptjm-29	473	1	bellingham mc	PERSON
bptjm-29	474	1	the last decade	DATE
bptjm-29	475	1	cns neurosci	ORG
bptjm-29	476	1	2011;17(1):4-31	ORG
bptjm-29	477	1	doi:10.1111	ORG
bptjm-29	479	1	july 24	DATE
bptjm-29	479	2	2022	DATE
bptjm-29	480	1	46 33	DATE
bptjm-29	481	1	smith a. riluzole	PERSON
bptjm-29	481	2	median berkeley pharma tech journal	ORG
bptjm-29	481	3	100	CARDINAL
bptjm-29	482	1	degener neurol neuromuscul dis	ORG
bptjm-29	483	1	2017;7:61-70	CARDINAL
bptjm-29	484	1	34	CARDINAL
bptjm-29	485	1	andrews ja	PERSON
bptjm-29	485	2	jackson ce	PERSON
bptjm-29	485	3	heiman-patterson	PERSON
bptjm-29	485	4	brooks br	ORG
bptjm-29	485	5	pioro ep	PERSON
bptjm-29	487	1	amyotroph lateral scler	ORG
bptjm-29	488	1	2020;21(7-8):509-518	CARDINAL
bptjm-29	489	1	35	CARDINAL
bptjm-29	491	1	the als association	ORG
bptjm-29	492	1	july 24	DATE
bptjm-29	492	2	2022	CARDINAL
bptjm-29	493	1	36	CARDINAL
bptjm-29	497	1	umea	ORG
bptjm-29	497	2	sweden	GPE
bptjm-29	497	3	umea university	ORG
bptjm-29	497	4	2018	DATE
bptjm-29	498	1	37	CARDINAL
bptjm-29	498	2	mitsubishi tanabe pharma development america, inc.	ORG
bptjm-29	498	3	3b	CARDINAL
bptjm-29	498	4	48 weeks	DATE
bptjm-29	499	1	2022	CARDINAL
bptjm-29	499	2	july 21	DATE
bptjm-29	499	3	2022	CARDINAL
bptjm-29	500	1	4 38	DATE
bptjm-29	501	1	two	CARDINAL
bptjm-29	501	2	only two	CARDINAL
bptjm-29	502	1	july 24	DATE
bptjm-29	502	2	2022	CARDINAL
bptjm-29	503	1	655-4 39	PERCENT
bptjm-29	505	1	july 24	DATE
bptjm-29	505	2	2022	CARDINAL
bptjm-29	506	1	40	CARDINAL
bptjm-29	507	1	october 12	DATE
bptjm-29	507	2	2022	CARDINAL
bptjm-29	508	1	945 41	CARDINAL
bptjm-29	509	1	als drug	ORG
bptjm-29	509	2	fda	ORG
bptjm-29	510	1	october 12	DATE
bptjm-29	510	2	2022	CARDINAL
bptjm-29	511	1	https://www.biopharmadive.com/news/amylyx-fda-appr	ORDINAL
bptjm-29	511	2	42	DATE
bptjm-29	512	1	nejm	CARDINAL
bptjm-29	513	1	july 24	DATE
bptjm-29	513	2	2022	CARDINAL
bptjm-29	514	1	https://www.nejm.org/doi/10.1056/nejmoa1916945 43	ORG
bptjm-29	515	1	slutsky sg	PERSON
bptjm-29	517	1	2020;14:824	CARDINAL
bptjm-29	517	2	44	CARDINAL
bptjm-29	519	1	als	ORG
bptjm-29	520	1	california	GPE
bptjm-29	521	1	july 23	DATE
bptjm-29	521	2	2022	CARDINAL
bptjm-29	522	1	july 24	DATE
bptjm-29	522	2	2022	CARDINAL
bptjm-29	523	1	45	CARDINAL
bptjm-29	524	1	als sciencedirect	ORG
bptjm-29	524	2	july 24	DATE
bptjm-29	524	3	2022	CARDINAL
bptjm-29	525	1	8010217305473#	CARDINAL
bptjm-29	526	1	mooney	PERSON
bptjm-29	527	1	sci	ORG
bptjm-29	529	1	47	DATE
bptjm-29	531	1	berkeley pharma tech journal	ORG
bptjm-29	531	2	101	CARDINAL
bptjm-29	532	1	biotechnol adv	PERSON
bptjm-29	533	1	2018;36(4):1111-1126	ORG
bptjm-29	534	1	doi:10.1016	GPE
bptjm-29	534	2	48	CARDINAL
bptjm-29	537	1	2013;85(1):3-10	DATE
bptjm-29	538	1	49	DATE
bptjm-29	540	1	2018;160:1-22	CARDINAL
bptjm-29	541	1	doi:10.1016	GPE
bptjm-29	541	2	50	CARDINAL
bptjm-29	542	1	fuchs e	PERSON
bptjm-29	542	2	weissman	PERSON
bptjm-29	543	1	ann n y acad sci	PERSON
bptjm-29	544	1	2020;1462(1):27-36	DATE
bptjm-29	545	1	doi:10.1111	ORG
bptjm-29	545	2	51	CARDINAL
bptjm-29	546	1	agrawal m	PERSON
bptjm-29	546	2	alexander	PERSON
bptjm-29	546	3	khan j	PERSON
bptjm-29	548	1	curr	ORG
bptjm-29	549	1	2019;14(2):127-136	CARDINAL
bptjm-29	550	1	lo b	PERSON
bptjm-29	550	2	parham l.	PERSON
bptjm-29	552	1	2009;30(3):204	CARDINAL
bptjm-29	552	2	213	CARDINAL
bptjm-29	553	1	0031 53	DATE
bptjm-29	554	1	shi y	PERSON
bptjm-29	554	2	inoue h	PERSON
bptjm-29	554	3	wu jc	PERSON
bptjm-29	554	4	yamanaka s.	PERSON
bptjm-29	554	5	a decade	DATE
bptjm-29	555	1	nat rev drug discov	PERSON
bptjm-29	556	1	2017;16(2):115-130	CARDINAL
bptjm-29	557	1	doi:10.1038	ORG
bptjm-29	557	2	54	CARDINAL
bptjm-29	558	1	salem hk	GPE
bptjm-29	558	2	thiemermann c. mesenchymal	PRODUCT
bptjm-29	559	1	stem cells	PERSON
bptjm-29	559	2	ohio	GPE
bptjm-29	560	1	2010;28(3):585-596	CARDINAL
bptjm-29	561	1	55	CARDINAL
bptjm-29	562	1	pmc	ORG
bptjm-29	563	1	july 24	DATE
bptjm-29	563	2	2022	CARDINAL
bptjm-29	564	1	671/ 56	DATE
bptjm-29	565	1	vasanthan j	PERSON
bptjm-29	570	1	july 24	DATE
bptjm-29	570	2	2022	DATE
bptjm-29	572	1	58	DATE
bptjm-29	573	1	jiménez-luna	PERSON
bptjm-29	573	2	perales-adán j	ORG
bptjm-29	573	3	melguizo	PERSON
bptjm-29	573	4	j. di�	PERSON
bptjm-29	574	1	biomol	PERSON
bptjm-29	575	1	2020;28(1):34-44	DATE
bptjm-29	576	1	59	CARDINAL
bptjm-29	577	1	toh ws	PERSON
bptjm-29	577	2	lai rc	PERSON
bptjm-29	577	3	zhang b	PERSON
bptjm-29	577	4	lim	PERSON
bptjm-29	577	5	msc exosome	PERSON
bptjm-29	579	1	2018;46(4):843-853	CARDINAL
bptjm-29	580	1	doi:10.1042/bst20180079 60	ORG
bptjm-29	581	1	ghannam	PERSON
bptjm-29	581	2	bou	ORG
bptjm-29	581	3	djouad f	PERSON
bptjm-29	581	4	jorgensen c	ORG
bptjm-29	583	1	2010;1(1):2	CARDINAL
bptjm-29	584	1	doi:10.1186/scrt2 61	ORG
bptjm-29	586	1	july 24	DATE
bptjm-29	586	2	2022	CARDINAL
bptjm-29	588	1	62	CARDINAL
bptjm-29	591	1	july 24	DATE
bptjm-29	591	2	2022	DATE
bptjm-29	591	3	63	DATE
bptjm-29	592	1	bhartiya	ORG
bptjm-29	592	2	d.	NORP
bptjm-29	592	3	oct-4	ORG
bptjm-29	593	1	hindawi	PERSON
bptjm-29	594	1	2013	DATE
bptjm-29	595	1	https://doi.org/10.1155/2013/547501 berkeley pharma tech journal	ORG
bptjm-29	595	2	102 64	DATE
bptjm-29	596	1	shen cn	PERSON
bptjm-29	596	2	burke zd	PERSON
bptjm-29	596	3	tosh d. transdi	PERSON
bptjm-29	598	1	2004;1(2):36	CARDINAL
bptjm-29	600	1	july 24	DATE
bptjm-29	600	2	2022	CARDINAL
bptjm-29	601	1	.0011 66	DATE
bptjm-29	604	1	july 24	DATE
bptjm-29	604	2	2022	CARDINAL
bptjm-29	605	1	2177515000047 67	DATE
bptjm-29	606	1	july 24	DATE
bptjm-29	606	2	2022	CARDINAL
bptjm-29	607	1	486/ 68	DATE
bptjm-29	608	1	plos one	FAC
bptjm-29	609	1	july 24	DATE
bptjm-29	609	2	2022	DATE
bptjm-29	611	1	mancuso	PERSON
bptjm-29	611	2	glynn	PERSON
bptjm-29	611	3	barry f	PERSON
bptjm-29	611	4	murphy jm	PERSON
bptjm-29	612	1	bioeng biotechnol	GPE
bptjm-29	613	1	july 24	DATE
bptjm-29	613	2	2022	CARDINAL
bptjm-29	614	1	9.00009 70	CARDINAL
bptjm-29	615	1	paliwal s	PERSON
bptjm-29	615	2	chaudhuri	ORG
bptjm-29	615	3	mohanty s. regenerative	PERSON
bptjm-29	617	1	2018;25(1):31	CARDINAL
bptjm-29	617	2	018-0429	CARDINAL
bptjm-29	618	1	petrou p	PERSON
bptjm-29	618	2	1/2	CARDINAL
bptjm-29	618	3	2a	CARDINAL
bptjm-29	619	1	jama neurol	PERSON
bptjm-29	621	1	doi:10.1001	GPE
bptjm-29	621	2	jamaneurol.2015.4321 72	DATE
bptjm-29	622	1	hematology &	ORG
bptjm-29	623	1	july 24	DATE
bptjm-29	623	2	2022	CARDINAL
bptjm-29	624	1	1756-8722-5-19 73	DATE
bptjm-29	625	1	nci dictionary	ORG
bptjm-29	625	2	nci	ORG
bptjm-29	626	1	february 2, 2011	DATE
bptjm-29	627	1	august 5	DATE
bptjm-29	627	2	2022	CARDINAL
bptjm-29	629	1	74	CARDINAL
bptjm-29	631	1	rinchetti p	ORG
bptjm-29	633	1	2014;5(4):87	CARDINAL
bptjm-29	633	2	75	CARDINAL
bptjm-29	634	1	zhang s	PERSON
bptjm-29	634	2	chen h.	PERSON
bptjm-29	636	1	berkeley pharma tech journal	ORG
bptjm-29	636	2	103	CARDINAL